Table 2.

Prophylactic antiemetic treatment with high emetogenic potential

Day 1	Day 2	Day 3	Day 4
Option A
5HT-3 receptor antagonista
Dexamethasone 12 mg PO/IV	Dexamethasone 8 mg PO/IV daily	Dexamethasone 8 mg PO/IV daily	Dexamethasone 8 mg PO/IV daily
Aprepitant or Fosaprepitant	Aprepitant	Aprepitant
Option B
NEPA = Netupitant 300 mg/palonosetron 0.5 mg PO
Dexamethasone 12 mg PO/IV	Dexamethasone 8 mg PO/IV daily	Dexamethasone 8 mg PO/IV daily	Dexamethasone 8 mg PO/IV daily
Option C
Olanzapine 10 mg PO	Olanzapine 10 mg PO daily	Olanzapine 10 mg PO daily	Olanzapine 10 mg PO daily
Palonosetron 0.25 mg IV
Dexamethasone 20 mg PO/IV

^aPalonosetron is advised because of its superiority in controlling delayed emesis